NYSE: LH
Labcorp Holdings Inc Stock

$246.27+3.90 (+1.61%)
Updated May 15, 2025
LH Price
$246.27
Fair Value Price
N/A
Market Cap
$20.61B
52 Week Low
$191.97
52 Week High
$258.59
P/E
28.24x
P/B
2.48x
P/S
1.48x
PEG
0.93x
Dividend Yield
0.58%
Revenue
$13.18B
Earnings
$730.80M
Gross Margin
27.9%
Operating Margin
8.76%
Profit Margin
5.5%
Debt to Equity
1.12
Operating Cash Flow
$2B
Beta
0.63
Next Earnings
N/A
Ex-Dividend
May 29, 2025
Next Dividend
Jun 11, 2025

LH Overview

Laboratory Corporation of America Holdings, a clinical laboratory company, offers tests (blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests). The company also provides gene-based and esoteric testing, and advanced tests targeting specific diseases. LabCorp was founded in 1971 and is headquartered in Burlington, NC.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine LH's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
C
LH
Ranked
#11 of 43

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$42.24A
$12.74B
$80.90B
View Top Diagnostic & Research Stocks

Be the first to know about important LH news, forecast changes, insider trades & much more!

LH News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LH ($246.27) is trading above its intrinsic value of $136.21, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LH is poor value based on its earnings relative to its share price (28.24x), compared to the US market average (26.06x)
P/E vs Market Valuation
LH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more LH due diligence checks available for Premium users.

Valuation

LH price to earnings (PE)

For valuing profitable companies with steady earnings

Company
28.24x
Industry
19.87x
Market
26.06x
LH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

LH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.48x
Industry
3.36x
LH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LH price to earnings growth (PEG)

For valuing profitable companies with growth potential

LH is good value based... subscribe to Premium to read more.
PEG Value Valuation

LH's financial health

Profit margin

Revenue
$3.3B
Net Income
$212.8M
Profit Margin
6.4%
LH's Earnings (EBIT) of $1.15B... subscribe to Premium to read more.
Interest Coverage Financials
LH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.6B
Liabilities
$9.3B
Debt to equity
1.12
LH's short-term assets ($3.79B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LH's long-term liabilities ($7.22B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$18.5M
Investing
-$336.0M
Financing
-$839.7M
LH's operating cash flow ($1.63B)... subscribe to Premium to read more.
Debt Coverage Financials

LH vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
LHC$20.61B+1.61%28.24x2.48x
NTRAC$20.40B-1.28%-101.63x16.46x
WATB$20.92B+1.80%31.79x10.66x
DGXC$19.69B+2.28%22.02x2.84x
MTDC$23.76B+2.29%28.42x-130.57x

Labcorp Holdings Stock FAQ

What is Labcorp Holdings's quote symbol?

(NYSE: LH) Labcorp Holdings trades on the NYSE under the ticker symbol LH. Labcorp Holdings stock quotes can also be displayed as NYSE: LH.

If you're new to stock investing, here's how to buy Labcorp Holdings stock.

What is the 52 week high and low for Labcorp Holdings (NYSE: LH)?

(NYSE: LH) Labcorp Holdings's 52-week high was $258.59, and its 52-week low was $191.97. It is currently -4.76% from its 52-week high and 28.29% from its 52-week low.

How much is Labcorp Holdings stock worth today?

(NYSE: LH) Labcorp Holdings currently has 83,700,000 outstanding shares. With Labcorp Holdings stock trading at $246.27 per share, the total value of Labcorp Holdings stock (market capitalization) is $20.61B.

Labcorp Holdings stock was originally listed at a price of $4.38 in Dec 31, 1997. If you had invested in Labcorp Holdings stock at $4.38, your return over the last 27 years would have been 5,529.03%, for an annualized return of 16.1% (not including any dividends or dividend reinvestments).

How much is Labcorp Holdings's stock price per share?

(NYSE: LH) Labcorp Holdings stock price per share is $246.27 today (as of May 15, 2025).

What is Labcorp Holdings's Market Cap?

(NYSE: LH) Labcorp Holdings's market cap is $20.61B, as of May 16, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Labcorp Holdings's market cap is calculated by multiplying LH's current stock price of $246.27 by LH's total outstanding shares of 83,700,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.